Advertisement

Search Results for "Pregnancy Pulmonary Hypertension Review"

05:35 EDT 25th May 2013 | BioPortfolio

Original Source: Pulmonary hypertension and pregnancy-a review of 12 pregnancies in nine women.

Please cite this paper as: Curry R, Fletcher C, Gelson E, Gatzoulis M, Woolnough M, Richards N, Swan L, Steer P, Johnson M. Pulmonary hypertension and pregnancy-a review of 12 pregnancies in nine women. BJOG 2012; DOI: 10.1111/j.1471-0528.2012.03295.x. Objective  To report outcomes in a recent series of pregnancies in women with pulmonary hypertension (PH). Design  Retrospective case note review. Setting  Tertiary referral unit (Chelsea and Westminster and Royal Brompton Hospitals). Sample  Twelve p...

Matching Channels

Hypertension in Pregnancy

Pulmonary Hypertension

Pulmonary hypertension groups 2 to 5

Pulmonary arterial hypertension group 1

Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of an affected individual. T...

Matching News

Pulmonary Hypertension Treated Effectively With Riociguat

Riociguat demonstrated efficacy and safety in pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension. Medscape Medical News

FDA grants priority review for Bayer HealthCare's riociguat for treatment of CTEPH

Bayer HealthCare announced today that the New Drug Application for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug Admini...

Bayer’s Riociguat for Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary ...

Riociguat is the first drug that has consistently demonstrated efficacy in two life-threatening PH indications - chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertensi...

Bayer's riociguat gets Priority Review

Bayer AG (Xetra:BAYN) said FDA accepted and granted Priority Review to an NDA for riociguat to treat pulmonary arterial hypertension (PAH) and inoperable chronic thromboembolic pulmonary hypertension...

Miocardin in Pulmonary arterial hypertension

So, what is pulmonary hypertension (PH) is an increase in blood pressure in the pulmonary artery, pulmonary vein, or pulmonary [...]

Bayer submits Japanese application for riociguat

Bayer AG (Xetra:BAYN) submitted a regulatory application in Japan for riociguat to treat chronic thromboembolic pulmonary hypertension (CTEPH). The oral soluble guanylyl cyclase (sGC) stimulator is un...

Bayer's Investigational Riociguat Granted U.S. FDA Priority Review

Bayer HealthCare announced today that the New Drug Application (NDA) for its oral investigational compound riociguat has been accepted for filing and granted priority review by the U.S. Food and Drug...

Assessment and treatment of right ventricular failure

Right ventricular failure is a complex problem with several possible aetiologies—including pulmonary hypertension, cardiomyopathy, myocardial infarction, congenital or valvular heart disease, and se...

Matching PubMed Articles

Pregnancy in women with pulmonary hypertension.

Women with pulmonary hypertension have a high risk of morbidity and mortality during pregnancy. The inability to increase cardiac output leads to heart failure while further risks are introduced with...

Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy.

Idiopathic pulmonary arterial hypertension is a rare condition associated with significant maternal mortality. We report the management of a 37-year-old multigravida with severe disease using epoprost...

Chronic Thromboembolic Pulmonary Hypertension.

Chronic thromboembolic pulmonary hypertension can develop after acute pulmonary embolus but is often overlooked until pulmonary hypertension has led to dyspnea and right ventricular dysfunction. This...

Schistosomiasis and pulmonary hypertension.

Schistosomiasis is one of the most prevalent chronic infectious diseases in the world. One of its most severe complications, pulmonary hypertension, occurs in up to 5% of patients with hepatosplenic s...

Mechanisms and Management of Hypertension in Pregnant Women.

Hypertension is the most common medical disorder encountered during pregnancy. A recent report highlighted hypertensive disorders as one of the major causes of pregnancy-related maternal deaths in the...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement